Evaluation of Risks Related to the Use of Adeno-Associated Virus-Based Vectors

Publisher： Bentham Science Publishers

E-ISSN： 1875-5631|3|6|545-565

ISSN： 1566-5232

Source： Current Gene Therapy, Vol.3, Iss.6, 2003-12, pp. : 545-565

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Safety of adeno-associated virus gene therapy vectors: a current evaluation

By Monahan Paul E   Jooss Karin   Sands Mark S  

Expert Opinion on Drug Safety, Vol. 1, Iss. 1, 2002-05 ,pp. : 79-91

Informa Healthcare

Access to resources Recommend Favorite

Adeno-Associated Virus Vectors: Immunobiology and Potential Use for Immune Modulation

By  

Current Gene Therapy, Vol. 12, Iss. 4, 2012-08 ,pp. : 333-343

Bentham Science Publishers

Access to resources Recommend Favorite

Adeno-Associated Virus (AAV) Vectors in the CNS

By  

Current Gene Therapy, Vol. 5, Iss. 3, 2005-06 ,pp. : 333-338

Bentham Science Publishers

Access to resources Recommend Favorite

Immune Responses to Adeno-Associated Virus Vectors

By  

Current Gene Therapy, Vol. 5, Iss. 3, 2005-01 ,pp. : 323-331

Bentham Science Publishers

Access to resources Recommend Favorite

Adeno-Associated Virus (AAV) Vectors in the CNS

By  

Current Gene Therapy, Vol. 11, Iss. 3, 2011-06 ,pp. : 181-188

Bentham Science Publishers

Access to resources Recommend Favorite